Several in vivo EAU studies have demonstrated capability of anti-ICAM-1 Ab and anti-LFA-1 Ab to ameliorate clinical severity in different EAU animal models but had no effect on experimental melanin-induced uveitis [38,39,40,41]. The gene discussed is ICAM1; the disease is uveitis.